| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697999 | Clinical Oncology | 2017 | 6 Pages |
Abstract
This study supports the use of proposed an 'upfront selection process' as a means of selecting patients for treatment with DIBH and avoiding two radiotherapy planning scans. Calculation of MHD can be used as a surrogate for mean heart dose in the selection of cases for DIBH.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N. Tanna, R. McLauchlan, S. Karis, C. Welgemoed, D.M. Gujral, S.J. Cleator,